Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 90
Selected: 0
NCT IDTitle
NCT01261741Investigation of Memantine in the Treatment of Memory, Concentration or Attention Problems
NCT00407030IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Cervical Dystonia
NCT00955799Efficacy, Safety, Tolerability of Neramexane in Patients With Subjective Tinnitus
NCT00909883Foot Dystonia Treatment by Botulinum Toxin Injections in Parkinson Disease : Efficiency of Injections Made in Extrinsic Muscle (Flexor Digitorum Longus Muscle) Compared to Intrinsic Muscle (Flexor Digitorum Brevis or Quadratus Plantae Muscles)
NCT00541723Efficacy and Safety of NT 201 in the Treatment of Lateral Periorbital Wrinkles
NCT00406367IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Blepharospasm
NCT06995287Evaluation of the Analgesic Effect of Intramyometrial Botulinum Toxin Injection Via Hysteroscopy in Severe Primary Dysmenorrhea
NCT01905683Long-term Open-label Study of Botulinumtoxin Type A to Treat Spasticity of Leg(s) or Leg(s) and Arm in Cerebral Palsy
NCT00872898Study of Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Children With Autism
NCT03650387Safety, Effectiveness and Participant Satisfaction Study of a Dermal Filler (of RADIESSE® (+) Lidocaine) in the Treatment of Ageing Signs in the Face
NCT00405886Neramexane for Tinnitus
NCT00915174Study to Evaluate the Effects of Neramexane on the Pharmacokinetics of a Combined Drospirenone/Ethinyl Estradiol Oral Contraceptive in Healthy Female Subjects
NCT02270736Clinical Study to Investigate the Efficacy and Safety of NT 201 Compared to Placebo in the Treatment of Chronic Troublesome Drooling Associated With Neurological Disorders and/or Intellectual Disability
NCT01910896Effectiveness and Safety Study of Overnight Intensive Patch in Scars
NCT00772980Efficacy, Safety and Tolerability of Neramexane in Comparison to Placebo in Patients With Subjective Tinnitus
NCT00827008Open-Label, Long-Term Treatment Study, to Assess the Long-Term Safety and Tolerability and Efficacy of Neramexane in Patients With Subjective Tinnitus
NCT01112371Contractubex Treatment in Scars After Abdominal Caesarean Section
NCT00432666IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Post-stroke Spasticity of the Upper Limb
NCT00799942Open-lable Extension Study on Safety and Efficacy of Neramexane to Treat Congenital and Acquired Nystagmus
NCT04908423Xeomin® and Gait Related Mobility After Stroke
NCT07473635Perineural Incobotulinumtoxin-A for Complex Regional Pain Syndrome - An Open-label Feasibility Study
NCT00739635Efficacy, Safety and Tolerability of Neramexane in Patients With Subjective Tinnitus
NCT01486264Open-Label Non-Inferiority Study Evaluating the Efficacy and Safety of Xeomin® in Subjects With Cervical Dystonia Flex
NCT03119948Partial Blocks of Rectus Femoris and Soleus With Botulinum Toxin Type A (Xeomin®) to Improve Gait in Hemiparesis
NCT04177212Investigation of the Effectiveness and Safety of MRZF111 in the Treatment of Décolleté Wrinkles
NCT07486830IncobotulinumtoxinA for Provoked Vestibulodynia With Overactive Pelvic Floor Muscle Dysfunction
NCT02462317Study of the Effects on Motor Recovery of Early Post-stroke Spasticity Treatment
NCT01098019Treatment of Notalgia Paresthetica With Xeomin
NCT00694148Safety and Efficacy of NT 201, Free of Complexing Proteins, in the Treatment of Glabellar Frown Lines
NCT00661440Efficacy and Safety Study of Neramexane to Treat Congenital and Acquired Nystagmus
NCT01999894Open-label Study of Safety and Tolerability of Memantine in Children With Autism
NCT03992404Study to Compare the Efficacy and Safety of NT 201 (Botulinum Toxin) With Placebo for the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic Brain Injury
NCT02091739Clinical Study to Investigate the Efficacy and Safety of Two Dose Levels of NT 201 Versus Placebo in Treating Chronic Troublesome Sialorrhea in Various Neurological Conditions
NCT00972127Changes in the Renal Excretion of Neramexane by Acidification of Urinary pH Study With and Without Application of a Urinary pH Acidification Regimen
NCT02188277Treatment With Xeomin Versus Botox in Children With Spastic Equine and Equinovarus Foot Deformation in Pediatric Cerebral Palsy
NCT01565395Incobotulinum Toxin A for Sialorrhea in Parkinson's Disease (PD)/Parkinsonism and Amyotrophic Lateral Sclerosis (ALS)
NCT00649220Memantine and Antipsychotics Use
NCT02577224An RCT of a Patient-initiated Treatment Service for BEB and HFS
NCT01603459Efficacy and Safety Dose Titration Study of Botulinum Toxin Type A to Treat Spasticity in the Leg and Arm
NCT01686061Blepharospasm Patient Survey for Patients With Blepharospasm
NCT03986424Local Study of Akatinol Memantine in VaD in Russia
NCT01405482Botulinum Toxin Injections for Thoracic Outlet Syndrome
NCT04594213Safety and Efficacy Study of the Simultaneous Treatment of Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines and Lateral Canthal Lines) in Subjects With Moderate to Severe Upper Facial Lines
NCT00983099Evaluation of Pharmacokinetics, Safety and Tolerability of Single and Multiple Oral Doses of Neramexane Mesylate in Healthy Japanese Subjects
NCT02002884Dose-response Study of Efficacy and Safety of Botulinum Toxin Type A to Treat Spasticity of the Arm(s) or of Arm(s) and Leg(s) in Cerebral Palsy
NCT04792398Bruxism Xeomin® Intervention Trial
NCT00804271Memantine and Validation of a New Alzheimer's Disease Scale
NCT04210258Post-Market Clinical Follow-up Performance and Safety Study of Etermis 3 and 4 in the Face
NCT00770029IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown Lines No. 2
NCT04622254Safety and Efficacy Study of the Simultaneous Treatment of Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines and Crows Feet) in Subjects With Moderate to Severe Upper Facial Lines